Zuberbühler Kathrin, Palumbo Alessandro, Bacci Camilla, Giovannoni Leonardo, Sommavilla Roberto, Kaspar Manuela, Trachsel Eveline, Neri Dario
Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zürich, Switzerland.
Protein Eng Des Sel. 2009 Mar;22(3):169-74. doi: 10.1093/protein/gzn068. Epub 2008 Nov 20.
The isolation of mammalian cell lines capable of high-yield expression of recombinant antibodies is typically performed by screening multiple individual clones by limiting dilution techniques. A number of experimental strategies have recently been devised to identify high-expressing clones, but protocols are often difficult to implement, time consuming, costly and limited in terms of number of clones which can be screened. In this article, we describe new vectors for the expression of recombinant antibodies in IgG format and in other formats, based on the single-chain Fv module, as well as a high-throughput screening procedure, based on the direct staining of antibodies transiting the membrane of a stably transfected cell, followed by preparative sorting using a high-speed cell sorter. This procedure allows, in one step, to deposit single cells into individual wells of a 96-well microtiter plate (thus facilitating cloning) and to preferentially recover those rare cell populations which express dramatically higher levels of recombinant antibody. Using cell cultures followed by affinity purification techniques, we could confirm that the new vectors and the new screening procedure reliably yield high-expression clones and homogenous protein preparations. We expect that these techniques should find broad applicability for both academic and industrial antibody engineering research.
能够高产表达重组抗体的哺乳动物细胞系的分离通常通过有限稀释技术筛选多个单个克隆来进行。最近已经设计出许多实验策略来鉴定高表达克隆,但方案往往难以实施、耗时、成本高,并且在可筛选的克隆数量方面有限。在本文中,我们描述了基于单链Fv模块的用于以IgG形式和其他形式表达重组抗体的新型载体,以及一种高通量筛选程序,该程序基于对穿过稳定转染细胞膜的抗体进行直接染色,然后使用高速细胞分选仪进行制备性分选。该程序允许一步将单个细胞沉积到96孔微量滴定板的各个孔中(从而便于克隆),并优先回收那些表达重组抗体水平显著更高的稀有细胞群体。通过细胞培养然后采用亲和纯化技术,我们可以确认新载体和新筛选程序能够可靠地产生高表达克隆和均一的蛋白质制剂。我们预计这些技术在学术和工业抗体工程研究中都将有广泛的应用。